Switzerland: Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Swiss Therapeutic Products Act Revision: A Step Forward In Digitalization

At the beginning of September 2025, the Swiss Federal Council published the dispatch for the partial revision of the Therapeutic Products Act (TPA).

Switzerland Healthcare

BK

Bär & Karrer

The Hague District Court Grants Injunction Against Glenmark For G-Standaard Listing Of Eltrombopag 14 Days Prior To SPC Expiry Novartis

This case concerns infringement by Glenmark on Novartis' SPC 300451 for eltrombopag (marketed as Revolade®). Novartis sought urgent relief after Glenmark included its generic "Eltrombopag Glenmark"...

Switzerland Healthcare

AO

A&O Shearman

Revision Des Heilmittelgesetzes (HMG): Erhöhte Medikationssicherheit Und Arzneimittel Für Neuartige Therapien

Am 3. September 2025 hat der Bundesrat die Botschaft zur Teilrevision des HMG zuhanden des Parlaments verabschiedet.

Switzerland Healthcare

BK

Bär & Karrer

Revision Of The Therapeutic Products Act (TPA): Increased Medication Safety And Advanced Therapy Medicinal Products

On 3 September 2025, the Federal Council published the dispatch regarding the partial revision of the Therapeutic Products Act (TPA) to be submitted to Parliament.

Switzerland Healthcare

BK

Bär & Karrer

Healthcare: Medical Devices 2025

Switzerland Healthcare

BK

Bär & Karrer

Cost Containment Measures In Switzerland Regarding Pharmaceuticals: Pricing Models Under Current And New Law

Switzerland Healthcare

BK

Bär & Karrer

Swiss Federal Supreme Court Prohibits The Use Of Animal Species Names For Plant-Based Meat Substitutes

Switzerland Healthcare

LS

Lenz & Staehelin

Life Sciences 2025

Switzerland Healthcare

BK

Bär & Karrer

Deal Ticker: Kellerhals Carrard Advised MoonLake Immunotherapeutics On Debt Financing With Hercules Capital, Inc.

Switzerland Healthcare

KC

Kellerhals Carrard

Patients' Rights And Artificial Intelligence In Switzerland

Switzerland Healthcare

BK

Bär & Karrer

Life Sciences 2025

Switzerland Healthcare

BK

Bär & Karrer

Five Years Of Switzerland's Revised Integrity, Transparency And Discounts Framework: Current Status And Emerging Enforcement Trends

Switzerland Healthcare

BK

Bär & Karrer

Pharmaceutical Advertising 2025

Switzerland Healthcare

BK

Bär & Karrer

Managing Health Data In Switzerland: Navigating Cross-Border CH/EU Challenges

Switzerland Healthcare

BK

Bär & Karrer

Revision Of The Therapeutic Products Act (TPA): Increased Medication Safety And Advanced Therapy Medicinal Products

Switzerland Healthcare

BK

Bär & Karrer

Derivatives Switzerland 2025 Edition - Law And Practice

Switzerland Finance

SW

Schellenberg Wittmer Ltd

IPO Comparative Guide

Switzerland Commercial

KC

Kellerhals Carrard

In-House View - Swiss M&A - Post-Merger Integration

Switzerland Commercial

PL

Pestalozzi Attorneys at Law

Swiss Anti-Money-Laundering Regulation Revised: New Transparency Register And New Rules For Advisors

Switzerland Finance

BK

Bär & Karrer

See more

Food and Drugs Law

Swiss Therapeutic Products Act Revision: A Step Forward In Digitalization

At the beginning of September 2025, the Swiss Federal Council published the dispatch for the partial revision of the Therapeutic Products Act (TPA).

Switzerland Healthcare

BK

Bär & Karrer

Revision Des Heilmittelgesetzes (HMG): Erhöhte Medikationssicherheit Und Arzneimittel Für Neuartige Therapien

Am 3. September 2025 hat der Bundesrat die Botschaft zur Teilrevision des HMG zuhanden des Parlaments verabschiedet.

Switzerland Healthcare

BK

Bär & Karrer

A Turning Point For Fiduciary Accountability: PBM-Owned Rebate Aggregators In The Spotlight

In 2025, federal scrutiny of Pharmacy Benefit Managers (PBMs) has reached a level not seen before. What was once tolerated as opaque and self-serving practices is now the subject of a coordinated...

Switzerland Accounting

BI

Buchanan Ingersoll & Rooney PC

Cost Containment Measures In Switzerland Regarding Pharmaceuticals: Pricing Models Under Current And New Law

Switzerland Healthcare

BK

Bär & Karrer

Swiss Federal Supreme Court Prohibits The Use Of Animal Species Names For Plant-Based Meat Substitutes

Switzerland Healthcare

LS

Lenz & Staehelin

Life Sciences 2025

Switzerland Healthcare

BK

Bär & Karrer

Life Sciences 2025

Switzerland Healthcare

BK

Bär & Karrer

Panel Discussion: Supply Chain Disputes

Switzerland Litigation

BK

Bär & Karrer

"Burek King" Fails Against "BURGER KING" – The Federal Administrative Court Confirms Risk Of Confusion

M

MME

See more

Life Sciences, Biotechnology & Nanotechnology

Swiss Therapeutic Products Act Revision: A Step Forward In Digitalization

At the beginning of September 2025, the Swiss Federal Council published the dispatch for the partial revision of the Therapeutic Products Act (TPA).

Switzerland Healthcare

BK

Bär & Karrer

The Hague District Court Grants Injunction Against Glenmark For G-Standaard Listing Of Eltrombopag 14 Days Prior To SPC Expiry Novartis

This case concerns infringement by Glenmark on Novartis' SPC 300451 for eltrombopag (marketed as Revolade®). Novartis sought urgent relief after Glenmark included its generic "Eltrombopag Glenmark"...

Switzerland Healthcare

AO

A&O Shearman

Revision Des Heilmittelgesetzes (HMG): Erhöhte Medikationssicherheit Und Arzneimittel Für Neuartige Therapien

Am 3. September 2025 hat der Bundesrat die Botschaft zur Teilrevision des HMG zuhanden des Parlaments verabschiedet.

Switzerland Healthcare

BK

Bär & Karrer

Revision Of The Therapeutic Products Act (TPA): Increased Medication Safety And Advanced Therapy Medicinal Products

Switzerland Healthcare

BK

Bär & Karrer

Healthcare: Medical Devices 2025

Switzerland Healthcare

BK

Bär & Karrer

Cost Containment Measures In Switzerland Regarding Pharmaceuticals: Pricing Models Under Current And New Law

Switzerland Healthcare

BK

Bär & Karrer

Life Sciences 2025

Switzerland Healthcare

BK

Bär & Karrer

Deal Ticker: Kellerhals Carrard Advised MoonLake Immunotherapeutics On Debt Financing With Hercules Capital, Inc.

Switzerland Healthcare

KC

Kellerhals Carrard

Life Sciences 2025

Switzerland Healthcare

BK

Bär & Karrer

See more

Healthcare

Swiss Therapeutic Products Act Revision: A Step Forward In Digitalization

At the beginning of September 2025, the Swiss Federal Council published the dispatch for the partial revision of the Therapeutic Products Act (TPA).

Switzerland Healthcare

BK

Bär & Karrer

Revision Des Heilmittelgesetzes (HMG): Erhöhte Medikationssicherheit Und Arzneimittel Für Neuartige Therapien

Am 3. September 2025 hat der Bundesrat die Botschaft zur Teilrevision des HMG zuhanden des Parlaments verabschiedet.

Switzerland Healthcare

BK

Bär & Karrer

Revision Of The Therapeutic Products Act (TPA): Increased Medication Safety And Advanced Therapy Medicinal Products

On 3 September 2025, the Federal Council published the dispatch regarding the partial revision of the Therapeutic Products Act (TPA) to be submitted to Parliament.

Switzerland Healthcare

BK

Bär & Karrer

A Turning Point For Fiduciary Accountability: PBM-Owned Rebate Aggregators In The Spotlight

Switzerland Accounting

BI

Buchanan Ingersoll & Rooney PC

Healthcare: Medical Devices 2025

Switzerland Healthcare

BK

Bär & Karrer

Compulsory Health Insurance: Is An Exemption Possible?

Switzerland Insurance

VA

Vischer AG

Cost Containment Measures In Switzerland Regarding Pharmaceuticals: Pricing Models Under Current And New Law

Switzerland Healthcare

BK

Bär & Karrer

First Aid Kit At Work In Switzerland: What Employers Need To Know

Switzerland Employment

M

MME

Life Sciences 2025

Switzerland Healthcare

BK

Bär & Karrer

See more

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More